| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 06/12/2008 | US20080139570 e.g. N-[2-(6-{[(3,4-dichlorophenyl)methyl]amino}-2-(4-methoxyphenyl)-3-oxo-4-hydropyridino[2,3-b]pyrazin-4-yl)ethyl]acetamide; antidiabetic agent; abnormal lipid levels, cardiovascular disease, obesity, oily skin conditions, metabolic syndrome |
| 06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
| 06/12/2008 | US20080135803 Pyridyl derivatives with substituents of electrons push-pull effect; compounds are colorless and have high thermal and photo stability as well as high compatibility in liquid crystal host; can reduce threshold voltage of cholesteric reflective displays, saving power and extending lifetime of driver ICs |
| 06/12/2008 | CA2669996A1 Pyrrol derivatives, preparation and use of the same in therapy |
| 06/11/2008 | EP1930325A1 Process for producing optically active piperazine compound |
| 06/11/2008 | EP1930007A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 06/11/2008 | EP1490066B1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 06/11/2008 | CN101195597A 1-substituted-4,4-2 substituted thiosemicarbazide compounds, production method and uses of the same |
| 06/11/2008 | CN100393713C Therapeutic agents useful for treating pain |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385053 Functionalized compositions for improved immobilization |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132699 Process For the Preparation of Diazine Derivatives |
| 06/05/2008 | US20080132698 Use of N-oxide compounds in coupling reactions |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132511 Sulfonamide compounds |
| 06/05/2008 | US20080132507 Hydrazide Derivatives |
| 06/04/2008 | EP1926708A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
| 06/04/2008 | CN101193855A Substituted aryl oximes |
| 06/03/2008 | US7381822 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 06/03/2008 | US7381821 Reacting 4-(alpha-(p-chlorophenyl)benzyl)-1-leaving group-alkylpiperazine with protected 1-hydroxy-1-(4-(p-hydroxyphenyl)-3-butynyl)urea to form 1-(4-(p-(4-(alpha-(p-chlorophenyl)benzyl)-1-piperazin-1-ylalkyl)phenyl)-3-butynyl)-1-hydroxyurea; preparation of intermediates |
| 06/03/2008 | US7381728 growth hormone secretagogue receptors agonists; N-[3-(cis-3,5-Dimethyl-1-piperazinyl)-4-(methyloxy)phenyl]-5-(2-pyridinyl)-2-thiophenesulfonamide; synthesis through the coupling of the piperazine derivatives with sulfonylhalides or pentafluorophenyloxy protected derivatives, or through interconversion |
| 06/03/2008 | US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide |
| 05/29/2008 | WO2008062740A1 Nitrogenated fused ring compound and use thereof |
| 05/29/2008 | WO2008061270A1 Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6-piperazinedione) |
| 05/29/2008 | WO2008040649A3 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 05/29/2008 | US20080125442 Cathepsin K Inhibitors and Atherosclerosis |
| 05/29/2008 | US20080125430 New small molecule inhibitors of mdm2 and the uses thereof |
| 05/29/2008 | US20080125429 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents |
| 05/29/2008 | US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 05/29/2008 | CA2670282A1 A new method for preparing 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione) |
| 05/28/2008 | EP1924575A1 Anthranilamides for controlling invertebrate pests |
| 05/28/2008 | CN101189012A Phenyl and pyridyl LTA4H modulators |
| 05/28/2008 | CN100390235C Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390153C Intermediate for producing novel pyrazine derivatives |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378448 Diphenylether amide derivatives as opioid receptor antagonists |
| 05/27/2008 | US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 05/27/2008 | US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 05/27/2008 | US7378420 4-[(2,4-dichloro-phenyl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide; conjugated to polyethylene glycol; analgesic, antidiabetic and anticarcinogenic agent, antidepressant, anxiolytic agent |
| 05/22/2008 | WO2008060271A1 Sigma ligands for neuronal regeneration and functional recovery |
| 05/22/2008 | WO2008059702A1 Process for purification of polycyclic compounds, process for production of polycyclic compounds, and uses of polycyclic compounds |
| 05/22/2008 | WO2008058341A1 Inhibitors of kinase activity |
| 05/22/2008 | WO2008043087A3 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 05/22/2008 | WO2008029282A3 Aqueous formulation comprising an antitumor agent |
| 05/22/2008 | US20080119491 Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/22/2008 | US20080119486 Benzoyl-piperazine derivatives |
| 05/22/2008 | US20080119471 1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; chemokine receptor CCR1 antagonist; chemokine (MIP-1 alpha and RANTES) inhibitor; antiinflammatory agent; multiple sclerosis, rheumatoid arthritis |
| 05/22/2008 | CA2701959A1 Inhibitors of kinase activity |
| 05/22/2008 | CA2668766A1 Sigma ligands for neuronal regeneration and functional recovery |
| 05/21/2008 | EP1922073A1 New capped pyrazinoylguanidine sodium channel blockers |
| 05/21/2008 | EP1922072A2 Melanocortin receptor-specific piperazine compounds with diamine groups |
| 05/21/2008 | EP1562595B1 Diaryl ethers as opioid receptor antagonists |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | CN101184491A Selective apoptotic induction in cancer cells including activation of procaspase-3 |
| 05/21/2008 | CN101182313A Chemical synthesis technique of quinoxaline |
| 05/21/2008 | CN101182312A Pyrazinamide derivatives as well as preparation method and uses thereof |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375107 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2214685C Benzamidine derivatives their preparation and their use as anti-coagulants |
| 05/20/2008 | CA2191874C Novel processes and intermediates for the preparation of piperazine derivatives |
| 05/15/2008 | WO2008057995A2 Hcv protease inhibitors |
| 05/15/2008 | WO2008057862A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF |
| 05/15/2008 | WO2007138112A3 Compounds that interact with ion channels, in particular with ion channels from the kv family |
| 05/15/2008 | US20080114169 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
| 05/15/2008 | US20080113975 Thiourea compounds |
| 05/14/2008 | EP1919479A2 Melanocortin receptor-specific piperazine and keto-piperazine compounds |
| 05/14/2008 | EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/13/2008 | US7371861 Process for preparing ring-fluorinated aromatics |
| 05/13/2008 | US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields |
| 05/13/2008 | US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 05/08/2008 | WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108632 Hcv protease inhibitors |
| 05/08/2008 | US20080108606 Side effect reduction; antiproliferative agents; schizophrenia |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108595 Inhibitors of cathepsin s |
| 05/07/2008 | EP1917252A1 Pyrazine derivatives and use as pi3k inhibitors |
| 05/07/2008 | EP1917240A1 Immunosuppressant compounds and compositions |
| 05/07/2008 | EP1720842B1 Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds |
| 05/07/2008 | CN100386326C 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/06/2008 | US7368451 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 05/06/2008 | US7368450 Sodium channel blockers |
| 05/06/2008 | US7368448 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors |
| 05/06/2008 | US7368447 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |